Tag Archives: Medtronic

Julia Strandberg named as new Chief Business Leader for Philips’ Connected Care businesses

(IN BRIEF) Royal Philips has appointed Julia Strandberg as the Chief Business Leader of its Connected Care businesses, effective from April 24, 2023. Strandberg, who joins Philips from Pear Therapeutics, will become a member of Philips’ Executive Committee reporting to … Read the full press release

Medtronic chairman and CEO to participate at Goldman Sachs 39th Annual Global Healthcare Conference

DUBLIN, 30-May-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018, in Rancho Palos Verdes, Calif. Omar Ishrak, Medtronic … Read the full press release

Diabetes: US FDA approval for Medtronic’s Guardian(TM) Connect continuous glucose monitoring (CGM) system

 ‘Smart’ CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received … Read the full press release

Medtronic at the Advanced Technologies & Treatments for Diabetes (ATTD) 11th International Conference in Vienna, Austria, February 14-17

Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA, 14-Feb-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies & Treatments for … Read the full press release

Medtronic’s Neurovascular business unit received U.S. FDA clearance of the Riptide(TM) Aspiration System

New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke DUBLIN, 17-Jan-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, … Read the full press release

Medtronic plc announces leadership changes

Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company DUBLIN, 20-Dec-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic’s Asia Pacific (APAC) Region, has been … Read the full press release

Medtronic announces U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology

Azure(TM) with BlueSync(TM) Technology Improves Device Longevity  and Provides Automatic, Wireless Remote Patient Monitoring DUBLIN, 21-Nov-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers … Read the full press release

Medtronic to open Innovation Center at the Singapore-Sichuan Hi-Tech Innovation Park

Facilitating Clinical Training for Physicians and Advancing Local Healthcare Efficiency in Central and Western China DUBLIN, Ireland and CHENGDU, Sichuan, 11-Oct-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced the groundbreaking of its Chengdu Innovation Center at the Singapore-Sichuan Hi-Tech Innovation … Read the full press release

Medtronic: U.S. FDA approval for the Endurant(TM) II/IIs stent graft system

New Indication Expands Treatment Options for AAA Patients with Hostile Neck Anatomy DUBLIN, 11-Oct-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft … Read the full press release

High blood pressure: Medtronic to move forward with a new renal denervation pivotal trial

Published Simultaneously in The Lancet, the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA, 04-Sep-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced its intent … Read the full press release

Medtronic: global randomized clinical trial to evaluate one-month dual antiplatelet therapy (DAPT) in patients with the Resolute Onyx(TM) DES during percutaneous coronary intervention (PCI)

First-of-its-Kind Randomized Clinical Trial Will Evaluate One-Month DAPT in Patients Following PCI Procedures with the Newer-Generation Durable Polymer Resolute Onyx DES DUBLIN, 18-Aug-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced a global randomized clinical trial that will evaluate one-month … Read the full press release

Medtronic: treating paroxysmal atrial fibrillation with cryoballoon catheter ablation results in cost savings as compared to radiofrequency ablation

Data from Landmark Trial Published in the Journal of the American Heart Association DUBLIN, 03-Aug-2017 — /EuropaWire/ — A new health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT), was published today in the Journal of … Read the full press release

Study Showcases Economic Value of Earlier Patient Access to Medtronic Cardiac Resynchronization Therapy Devices

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced an economic analysis of five-year data showing that patients with mild heart failure who get cardiac resynchronization therapy (CRT) devices early in their treatment live longer and that implanting these devices … Read the full press release

Medtronic to present at the 37th Annual Cowen and Company Healthcare Conference on March 7, 2017

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc  (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on Tuesday, March 7, 2017, in Boston, Mass. Geoff Martha, executive vice president … Read the full press release

Medtronic presents results supporting the IN.PACT® Admiral® drug-coated balloon in patients with peripheral arterial disease

First Presentation of Results from Regional Cohorts of IN.PACT Global Study Reinforce Strong, Consistent and Safe Outcomes for PAD Patients  DUBLIN and LEIPZIG, 25-Jan-2017 — /EuropaWire/ — Medtronic today presented new data at the Leipzig Interventional Course (LINC) 2017 conference supporting … Read the full press release

Medtronic expands directional atherectomy portfolio in Europe with new 6F HawkOne

Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced CE (Conformité Européene) Mark approval for the HawkOne(TM) directional atherectomy system in a … Read the full press release

Medtronic announces first procedure using Visualase(TM) MRI-Guided Laser Ablation System for treatment of common form of epilepsy

DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) clinical trial at Mayo Clinic … Read the full press release

Medtronic: launch of the largest sized transcatheter aortic valve replacement (TAVR) system available in the U.S.

Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of … Read the full press release

Medtronic announced U.S. commercial availability of its MiniMed Connect mobile accessory for Android

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of … Read the full press release

Medtronic’s Hybrid Closed Loop system pivotal trial results published in the Journal of the American Medical Association

DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the Journal of the American Medical Association (JAMA). The data presented the safety of the system … Read the full press release

Medtronic announces the appointment of Mark Ploof as SVP, Global Operations and Business Services

DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016.  He will serve on the company’s Executive Committee and be responsible for leading … Read the full press release

Medtronic received Ministry of Health, Labor and Welfare approval for its Reveal LINQ Insertable Cardiac Monitor System in Japan

Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke  DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac … Read the full press release

Medtronic’s IN.PACT Admiral drug-coated balloon treatment for in-stent restenosis receives FDA approval

IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment for in-stent … Read the full press release

Medtronic plc SureTune2(TM) software receives CE Mark

New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data DUBLIN, 10-Aug-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune2(TM) software, which … Read the full press release

Diabetes Management: Medtronic announced new product developments and technology partnerships at the American Diabetes Association (ADA) 76th Scientific Sessions

CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016 DUBLIN and NEW ORLEANS, 10-Jun-2016 — /EuropaWire/ — Delivering on its vision to transform care for the millions currently living with … Read the full press release

Medtronic presents FIRE AND ICE clinical trial findings at a late-breaking session at CARDIOSTIM-EHRA EUROPACE 2016

Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes DUBLIN AND NICE, FRANCE, 10-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of theFIRE AND ICE clinical trial that demonstrate significantly fewer repeat … Read the full press release

Medtronic presents results of new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM / EHRA EUROPACE 2016

Places ICD Leads Under Rib Cage, Outside Heart and Veins DUBLIN and NICE, FRANCE, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NSYE: MDT) today announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM … Read the full press release

Medtronic / University of Texas: First patient enrolled in a clinical study for the minimally invasive repair of descending thoracic aortic aneurysms (TAA)

Unique Next-Generation Device Evaluated in International Clinical Trial; First Procedure Performed at the University of Texas Health Science Center at Houston DUBLIN and HOUSTON, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) and the University of Texas Health Science Center at … Read the full press release

Lung cancer: Medtronic announced European enrollment in the NAVIGATE clinical trial

NAVIGATE Study Assesses Impact of Minimally Invasive Technology to Aid in Early Diagnosis and Treatment of Lung Cancer DUBLIN, 14-Mar-2016 — /EuropaWire/ — Committed to technologies that assist in the goal of reducing lung cancer morbidity worldwide, Medtronic (NYSE: MDT) today … Read the full press release

Medtronic presented results of iPro2 Professional CGM at 9th International Conference on Advanced Technologies & Treatments for Diabetes

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016 — /EuropaWire/ — A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, … Read the full press release

Medtronic announced the availability of new CareLink® iPro report called Pattern Snapshot for iPro2 Professional CGM system

Simplified Report Uses New Algorithms to Streamline Diabetes Data Interpretation for the Health Care Professional DUBLIN, 1-12-2015 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the availability of a new CareLink® iPro report called Pattern Snapshot … Read the full press release

Medtronic: First implants of the TYRX(TM) Absorbable Antibacterial Envelope with Medtronic Deep Brain Stimulation (DBS) systems

DUBLIN, 9-10-2015 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced the first implants of the TYRX(TM) Absorbable Antibacterial Envelope with Medtronic Deep Brain Stimulation (DBS) systems. The implants were conducted by Francisco Ponce, M.D., director, Barrow Center for Neuromodulation, at the … Read the full press release

Medtronic to present notable clinical studies at Transcatheter Cardiovascular Therapeutics (TCT) symposium in San Francisco, Oct 11-15, 2015

Meeting Highlights New Two-Year Data on IN.PACT Admiral DCB, First Report of Real-World TVT Registry with CoreValve System, First One-Year Data on Recapturable Evolut R, and Initial Results on First Implants of Drug-Filled Stent DUBLIN, 8-10-2015 — /EuropaWire/ — Medtronic plc (NYSE: … Read the full press release

Medtronic demonstrates the durability of the Valiant® Thoracic Stent Graft System after five-year data in VALOR II Study

Valor II U.S. Study Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms DUBLIN and Newport, R.I., 8-10-2015 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced favorable five-year data in the VALOR II Study, demonstrating the durability of the Valiant® … Read the full press release

Sanofi and Medtronic partner to improve patient experience and outcomes for people with diabetes around the world

Initial focus on insulin-device combinations and care management services Paris and Minneapolis, Minn., 16-6-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to enter into a … Read the full press release